Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Immix Biopharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +12 vs. Q3 2023
- Shares held
- 781.8K
- +376.8K (+93.0%) vs. Q3 2023
- Total value
- $5.32M
- +$3.93M (+283.7%) vs. Q3 2023
- New holders
- 13
- 7 more added
- Sold out
- 1
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 68 | $0 | 0.00% | +68 | New |
| Advisor Group Holdings, Inc. | 350 | $2.42K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 391 | $2.71K | 0.00% | +334+586.0% | Added |
| Tower Research Capital LLC (TRC) | 577 | $3.99K | 0.00% | +577 | New |
| JPMorgan Chase & Co | 678 | $4.69K | 0.00% | +671+9,585.7% | Added |
| Tortoise Investment Management, LLC | 1,300 | $9.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,594 | $11.0K | 0.00% | +1,594 | New |
| UBS Group AG | 2,628 | $18.2K | 0.00% | +2,628 | New |
| Old National Bancorp | 10,000 | $69.2K | 0.00% | +10,000 | New |
| Bank of Montreal | 10,000 | $72.0K | 0.00% | +10,000 | New |
| InterOcean Capital Group, LLC | 11,900 | $82.3K | 0.00% | −4,000−25.2% | Reduced |
| Dimensional Fund Advisors LP | 11,915 | $82.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 14,351 | $99.3K | 0.00% | +14,351 | New |
| Jane Street Group, LLC | 14,922 | $103.3K | 0.00% | +14,922 | New |
| Morgan Stanley | 16,168 | $111.9K | 0.00% | +15,768+3,942.0% | Added |
| BlackRock Inc. | 17,712 | $122.6K | 0.00% | −279−1.6% | Reduced |
| Jump Financial, LLC | 18,500 | $128.0K | 0.00% | +18,500 | New |
| Moss Adams Wealth Advisors LLC | 20,000 | $138.4K | 0.03% | 00.0% | Unchanged |
| Tocqueville Asset Management L.P. | 20,000 | $138.4K | 0.00% | +8,000+66.7% | Added |
| Imprint Wealth LLC | 34,483 | $143.2K | 0.12% | +11,400+49.4% | Added |
| Northern Trust Corp | 24,378 | $168.7K | 0.00% | +24,378 | New |
| Commonwealth Equity Services, LLC | 28,300 | $196.0K | 0.00% | −555−1.9% | Reduced |
| Renaissance Technologies LLC | 32,400 | $224.0K | 0.00% | +32,400 | New |
| State Street Corp | 42,960 | $297.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 83,427 | $577.4K | 0.00% | +10,405+14.2% | Added |
| Private Advisor Group, LLC | 99,775 | $690.4K | 0.01% | +99,775 | New |
| EAM Investors, LLC | 102,661 | $710.4K | 0.13% | +102,661 | New |
| Vanguard Group Inc | 160,398 | $1.11M | 0.00% | +54,188+51.0% | Added |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −51,001−100.0% | Sold out |